Keywords: Amgen, Enbrel, New US patent, Roche, Reumatoid arthritis, Psoriasis

Amgen’s gets new US patent for Enbrel, giving protection until 2028

Article | 24 November 2011

Print This

Global biotech leader Amgen (Nasdaq: AMN) has announced the issuance of a new patent, US Patent No 8,063,182, related to its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in